Its beneficial effect, which has apparently been modest in the first year, could be subjected histological improvement, thus becoming the starting point in a change in the trajectory of patients
With data from this trial in hand, Lilly said, it now has the full clinical package needed to start filing for approvals of orforglipron with various regulators
Minas A, Fernandes ACC, Maciel Jnior VL, Adami L, Intasqui P, Bertolla RP
Therefore, successful long term management requires comprehensive blood testing and necessary Hormonal Resistance management alongside the GLP-1 therapy immediately
If it's legal, safe and efficacious, I'm a fan of better living through science, and the stack you've just discovered is one of the most potent ways to pull this off